New Reversible Covalent Warheads: Cyanobenzothiazoles Recruiting DCAF16 for Targeted Protein Degradation
Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 11620-11637
DOI: 10.1021/acs.jmedchem.6c00889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.04.2026. Verfasst von Jixian Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China. Hauptthemen laut MEDLINE: Proteolysis, Benzothiazoles, Cell Cycle Proteins, Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: MOE Key Laboratory of Tumor Molecular Biology Foundation, Natural Science Foundation of China, Science and Technology Project in Guangzhou.
Abstract (Originalsprache)
Protein N-terminal cysteines (NCys) are valuable for selective modification and posttranslational regulation, but their proteome-wide landscape remains unexplored. We constructed a library of electrophilic probes, including cyanobenzothiazole (CBT), to systematically map ligandable native NCys residues. Modifiable NCys sites were identified in proteins such as GFPT1 and CSTB, revealing accessible NCys in the human proteome. Integrating CBT into a BRD4-targeting ligand generated a reversible covalent degrader (DC50 = 16.7 nM, Dmax = 98%). Mechanistic studies showed that CBT modifies DCAF16 at Cys58, promoting ternary complex formation and enabling efficient ubiquitination and degradation. The platform achieved potent and selective degradation of challenging targets like EGFRL858R/T790M/C797S and HER2 without hook effects, outperforming clinical inhibitors. This work provides the first proteome-wide map of ligandable NCys residues and establishes CBT as a versatile platform for covalent targeted protein degradation (TPD), opening new avenues for precision therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
- International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development (MOE), Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
- School of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
- College of Pharmacy, Shihezi University, Shihezi 832003, China.
- MOE Key Laboratory of Tumor Molecular Biology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
ORCID-Profile: Yi Tan, Zhengqiu Li
Förderung
- MOE Key Laboratory of Tumor Molecular Biology Foundation
- Natural Science Foundation of China
- Science and Technology Project in Guangzhou
- Science and Technology Program of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Zhang, J., Huang, L., Li, S., Li, Y., Tan, Y., Liu, T., & Li, Z. (2026). New Reversible Covalent Warheads: Cyanobenzothiazoles Recruiting DCAF16 for Targeted Protein Degradation. Journal of Medicinal Chemistry, 69(9), 11620-11637. https://doi.org/10.1021/acs.jmedchem.6c00889
Vancouver
Zhang J, Huang L, Li S, Li Y, Tan Y, Liu T, et al. New Reversible Covalent Warheads: Cyanobenzothiazoles Recruiting DCAF16 for Targeted Protein Degradation. Journal of Medicinal Chemistry. 2026;69(9):11620-11637. doi:10.1021/acs.jmedchem.6c00889
BibTeX
@article{Zhang2026,
author = {Zhang, Jixian and Huang, Lei and Li, Shengrong and Li, Yifang and Tan, Yi and Liu, Tongzheng and Li, Zhengqiu},
title = {New Reversible Covalent Warheads: Cyanobenzothiazoles Recruiting DCAF16 for Targeted Protein Degradation},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {9},
pages = {11620--11637},
doi = {10.1021/acs.jmedchem.6c00889}
}
EUVIMED